Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2017 Mar;69(3):439–448. doi: 10.1002/acr.22820

Table 2. Differential diagnosis of cavitary pulmonary nodules(1).

Benign cavitating pulmonary lesions Malignant cavitating pulmonary lesions
Infectious Bacterial necrotizing pneumonia: S. pneumoniae, H. influenza, K. pneumoniae, S. aureus
Lung abscesses: Prevotella, Fusobacterium, and S. milleri group
Uncommon infections: Actinomyces, Burkholderia pseduomallei, and Rhodococcus equi.
Mycobacterial: M. tuberculosis, M. avium, M. intracellulare, M. malmoense, M. xenopi.
Fungal: Aspergillus sp., Zygomycetes, Histoplasma capsulatum, Blastomyces dermatidis, Coccidioides immitis, Coccidioides posadasii, Paracoccidioides brasiliensis, Cryptococcosis neoformans, Penicillum marneffei, Pneumocystis jiroveci
Primary Squamous Cell Carcinoma
Lymphoma (particularly in HIV)
Kaposi's Sarcoma
Lymphomatoid granulomatosis
Autoimmune Granulomatosis with polyangiitis
Sarcoidosis
Ankylosing Spondylitis
Rheumatoid nodules
Primary amyloidosis
Secondary Metastatic tumors of squamous cell origin are more likely to cavitate than tumors of other origins
Pulmonary Pulmonary Embolism
Bronchiolitis Obliterans Organizing Pneumonia (up to 6% may have cavitary lesions (55))
Pulmonary Langerhans' cell Histiocytosis